- Home
- MRTN vs PVLA Comparison
MRTN vs PVLA Comparison
Compare MRTN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRTN | PVLA |
|---|---|---|
| Founded | 1946 | 2015 |
| Country | United States | United States |
| Employees | N/A | 14 |
| Industry | Trucking Freight/Courier Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.6B |
| IPO Year | 1994 | N/A |
Fundamental Metrics
Financial Performance| Metric | MRTN | PVLA |
|---|---|---|
| Price | $17.34 | $110.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 15 |
| Target Price | N/A | ★ $171.87 |
| AVG Volume (30 Days) | ★ 790.3K | 225.6K |
| Earning Date | 04-23-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.61% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.02 | N/A |
| Revenue | ★ $1,131,455,000.00 | N/A |
| Revenue This Year | $2.23 | N/A |
| Revenue Next Year | $8.59 | $104,350.18 |
| P/E Ratio | $888.50 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.35 | $20.20 |
| 52 Week High | $18.48 | $151.18 |
Technical Indicators
Market Signals| Indicator | MRTN | PVLA |
|---|---|---|
| Relative Strength Index (RSI) | 55.69 | 47.74 |
| Support Level | $14.31 | $109.68 |
| Resistance Level | $18.48 | $118.23 |
| Average True Range (ATR) | 0.50 | 6.95 |
| MACD | -0.10 | 0.52 |
| Stochastic Oscillator | 25.16 | 53.90 |
Price Performance
Historical ComparisonAbout MRTN Marten Transport Ltd.
Marten Transport Ltd is a temperature-sensitive and dry truckload carrier in the United States. The company specializes in transporting and distributing food and other consumer packaged goods that require a temperature-controlled or insulated environment. The company operates through four segments: Truckload, Dedicated, Intermodal, and Brokerage, generating the majority of its revenue from the Truckload segment. The Truckload segment offers a mix of regional short-haul and medium- to long-haul full-load transportation services transporting food and other consumer packaged goods.
About PVLA Palvella Therapeutics Inc.
Palvella Therapeutics Inc is a late clinical-stage biopharmaceutical company committed to serving individuals suffering from serious, rare genetic skin diseases without approved therapies. The Company's lead product candidate, QTORIN 3.9 percent rapamycin anhydrous gel (QTORIN rapamycin), is based on the Company's patented QTORIN platform. QTORIN rapamycin is in clinical development for two rare genetic skin disorders.